IMMUNIC, INC.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
56
- −22 vs. Q1 2026
- Total value $134.5M
Superinvestors holding IMUX
0
- None of the superinvestors held IMUX at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by IMUX insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025Amended | Jun 5, 2025 | Tardio JasonPresident and COO | PPurchaseCommon Stock | +12.51K | $0.79 | +$9.88K | 12.51K | New position | SEC |
| Jun 20, 2025Amended | Jun 4, 2025 | Vitt DanielCEO and Director | PPurchaseCommon Stock | +15K | $0.77 | +$11.55K | 29K | +107.1% | SEC |
| Jun 16, 2025 | Jun 13, 2025 | Nash DuaneExecutive Chairman | PPurchaseCommon Stock | +20K | $0.83 | +$16.6K | 36.03K | +124.8% | SEC |
| Jun 5, 2025 | Jun 4 – Jun 5, 2025 | Neermann JoergDirector | PPurchaseCommon Stock | +100K | $0.767 | +$76.7K | 200K | +100.0% | SEC |
| Jun 4, 2025 | Jun 3, 2025 | Whaley GlennChief Financial Officer | PPurchaseCommon Stock | +45K | $0.71 | +$31.95K | 95.51K | +89.1% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in IMUX at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Standard Life Aberdeen plc | 824,393 | $12.67M | 0.02% | −7,419,548−90.0% | Reduced |
| BVF INC/IL | 765,295 | $11.76M | 0.30% | −6,887,677−90.0% | Reduced |
| MILLENNIUM MANAGEMENT LLC | 740,347 | $11.38M | 0.01% | −3,039,575−80.4% | Reduced |
| Avidity Partners Management LP | 669,941 | $10.3M | 1.65% | −6,699,411−90.9% | Reduced |
| BRAIDWELL LP | 645,010 | $9.91M | 0.37% | +645,010 | New |